Press Kit: Old Blood, New Life
Resources for press and podcast producers: cover art, author photos, bios at two lengths, a sample chapter, and suggested interview questions. Everything here is cleared for use in coverage of the book.
Book at a Glance
- Title
- Old Blood, New Life
- Authors
- Allen P. Green, MD, and Dobri Kiprov, MD
- Publisher
- Sanguine House
- Format
- Paperback
- Price
- $18.99
- ISBN
- 979-8-9970143-1-5
- Publication date
- August 28, 2026
Download Assets
Cover, print resolution →JPG, 1800 x 2700, 300 dpi
Cover, web resolution →JPG, 1000 x 1500
Dr. Green at the Amicus separator →JPG, 1400 x 1867
Dr. Green, formal headshot →JPG, 641 x 801, web resolution
Dr. Kiprov, headshot →JPG, 1168 x 1366, 300 dpi
Sample chapter: Chapter 3, Bleed to Heal →PDF, 12 pages
Need a larger file or a different crop? Email and we will send one.
Author Bios
Allen P. Green, MD, is board-certified in clinical pathology and serves as Associate Medical Director at Global Apheresis in Mill Valley, California. He trained in therapeutic apheresis and transfusion medicine at UT Southwestern Medical Center under Dr. Ravi Sarode, and has supervised over 500 therapeutic plasma exchange procedures. His work has appeared in peer-reviewed journals, and he has presented at the American Society for Apheresis and AABB. With Dr. Dobri Kiprov, he is co-author of Old Blood, New Life, a history of what medicine has believed about blood and an account of where the evidence for plasma exchange stands today.
Allen P. Green, MD, is board-certified in clinical pathology and serves as Associate Medical Director at Global Apheresis in Mill Valley, California. He trained in therapeutic apheresis and transfusion medicine at UT Southwestern Medical Center under Dr. Ravi Sarode, and has supervised over 500 therapeutic plasma exchange procedures.
Apheresis is a procedure practiced within transfusion medicine, itself a branch of clinical pathology. Few physicians offering plasma exchange today trained in the discipline that developed it. That background shapes how Dr. Green approaches the field: as a clinical pathologist first, attentive to what the evidence supports and to where the claims outrun it.
His work has appeared in peer-reviewed journals, and he has presented at the American Society for Apheresis and AABB. He writes at allenpgreenmd.com on therapeutic plasma exchange for clinicians and patients, including critical assessments of unproven procedures marketed under the apheresis label.
With Dr. Dobri Kiprov, one of the physicians who established therapeutic plasma exchange in clinical practice and who has overseen more than 15,000 treatments, he is co-author of Old Blood, New Life. The book traces what medicine has believed about blood from the ancient world through the long era of bloodletting to the present, and asks a question that sounds ridiculous until you look at the mechanisms: what did the humoralists get right, and what does the current evidence actually show about removing pathological factors from circulating plasma?
Dr. Green practices in Mill Valley, California.
Suggested Interview Questions
- Bloodletting killed people for two thousand years. Your book argues the doctors doing it were not stupid. What were they actually reasoning from?
- What is the difference between bloodletting and therapeutic plasma exchange, in plain terms?
- Plasma exchange has been standard care for certain neurological and autoimmune conditions for decades. Why do most people have no idea it exists?
- The AMBAR trial tested plasma exchange in Alzheimer's disease. What did it find, and what did it not find?
- Plasma exchange for Alzheimer's sits in ASFA Category III. What does that classification mean, and why does it matter that you say so?
- There is a lot of enthusiasm around blood-based longevity right now. Where does the science end and the marketing begin?
- Your site is unusually critical of some procedures marketed as blood filtration, EBOO in particular. What is the objection?
- Microplastics and PFAS are in essentially everyone's blood now. What can and cannot be done about that?
- What do we still not know? What would change your mind about this field?
- You trained under one of the physicians who helped establish this field, and you wrote the book with him. What has that been like?
- Who should not get plasma exchange?
- If a listener has a family member with an autoimmune condition and wants to know whether apheresis is relevant, what should they ask their own physician?
Contact
Booking inquiries by email preferred.
Buy the book: Old Blood, New Life.